To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure

QR Code

To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure

BackgroundMineralocorticoid receptor antagonists (MRAs) are pivotal in heart failure (HF) management.ObjectivesThis study evaluates their impact on adverse cardiovascular events and left ventricular ejection fraction (LVEF) in HF patients.MethodsA comprehensive literature search was conducted across...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinyu He, Gang Chen, Yujia Huo, Chunyu Zhang, Haojie Xue, Jing Wang, Yi Zhong, Juan Xiao, Hongping Shen, Jian Feng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	heart failure mineralocorticoid receptor antagonists all-cause mortality cardiovascular death meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1564860/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mineralocorticoid receptor overactivation-induced remodeling of obese adipose tissue
by: WEN Runzhi, WANG Li, ZHAO Naiqian
Published: (2025-06-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases
by: Jiao Wang, et al.
Published: (2025-08-01)

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
by: N. A. Nuritdinov, et al.
Published: (2020-12-01)

Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin
by: O. A. Osipova, et al.
Published: (2021-11-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

Pharmacokinetics and Safety of HRS-1780 in Renal Impaired Subjects: A Multicenter, Non-Randomized, Open-Label Study [Corrigendum]
by: Fei Y, et al.
Published: (2025-06-01)

The effectiveness of eplerenone in clinical practice from the standpoint of evidence-based medicine (twenty years on the guard of life)
by: A. G. Evdokimova, et al.
Published: (2023-01-01)

Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk
by: F. I. Belyalov, et al.
Published: (2016-09-01)

Efficacy and Safety of Low‐Dose Spironolactone in Management of Diabetic Kidney Disease in a Real‐World Setting
by: Manochehr Amini, et al.
Published: (2025-07-01)

Moscow and Moscow Oblast: Commonality and Specificity of Mortality Trends and Causes of Death
by: V. G. Semenova, et al.
Published: (2024-12-01)

Metabolic syndrome and the risk of cardiovascular and all-cause mortality: data of 14-year prospective cohort study in Siberia
by: G I Simonova, et al.
Published: (2020-07-01)

Effects of Statins on All-Cause Mortality in Patients with Breast Cancer: A Population-Based Study
by: Ching-Feng Cheng, et al.
Published: (2025-06-01)

Are there benefits of low doses of ACE inhibitors, MRAs, diuretics and statins in the treatment of heart failure?
by: V. А. Lysenko
Published: (2021-07-01)

Low apolipoprotein B and LDL-cholesterol are associated with the risk of cardiovascular and all-cause mortality: a prospective cohort
by: Xiaolin Yu, et al.
Published: (2025-12-01)

Hyperuricemia and hypertension in working-age people: results of a population study
by: S. A. Shalnova, et al.
Published: (2023-12-01)

The impact of depression on mortality among older adult patients with hypertension: a systematic review and meta-analysis
by: Ze Fang, et al.
Published: (2025-07-01)

ASSESSMENT OF THE QUALITY OF ACCOUNTING OF DEATHS OF PATIENTS WITH MALIGNANT NEOPLASMS IN RUSSIA
by: G. V. Petrova, et al.
Published: (2016-12-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Spatial convergence of mortality in Poland
by: Kuropka Ireneusz, et al.
Published: (2021-11-01)

Differences in cause of death and age at death between people with and without diabetes over 10 years (2010–2020): A cross‐sectional study in Japan
by: Hirofumi Sugimoto, et al.
Published: (2025-08-01)

ASSOCIATIONS OF ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION, AND THEIR IMPORTANCE FOR MORTALITY FROM CARDIOVASCULAR CAUSES AND ALL CAUSES, OF PEOPLE AGED MORE THAN 55 YEARS OLD
by: S. A. Shalnova, et al.
Published: (2015-12-01)

Clopidogrel monotherapy is associated with higher mortality risk compared to aspirin: a retrospective analysis of NHANES 1999–2018
by: Tieshi Zhu, et al.
Published: (2025-12-01)

Ischemic heart disease: medical certificate of cause of death analysis
by: I. V. Samorodskaya, et al.
Published: (2022-02-01)

ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)

Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: results from NHANES 2003 to 2018
by: Guangyu Wang, et al.
Published: (2025-07-01)

Influence of aldosterone antagonists on markers of electrophysiological instability in patients with heart failure with mid-range ejection fraction after ST-segment elevation acute coronary syndrome in the short- and long-term periods
by: L. V. Shekhovtsova, et al.
Published: (2020-11-01)

Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway – A register study
by: Gisle Langslet, et al.
Published: (2025-09-01)

Low lean mass and all-cause mortality risk in the middle-aged and older population: a dose-response meta-analysis of prospective cohort studies
by: Juan Li, et al.
Published: (2025-06-01)

Frequency of adverse outcomes in hypertensive patients aged 80 years and older depending on heart failure and frailty syndrome
by: V. A. Safronenko, et al.
Published: (2025-04-01)

BODY WEIGHT AND ITS IMPACT ON ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN RUSSIA
by: S. A. Shalnova, et al.
Published: (2014-02-01)

Usefulness of the AHEAD score for prediction of all-cause death in patients with acute and chronic coronary syndromes
by: Shunsuke Tamaki, et al.
Published: (2025-09-01)

Prognostic significance of skin autofluorescence in patients undergoing maintenance hemodialysis
by: Darya Yu. Konovalova, et al.
Published: (2025-01-01)

Prediabetes: prevalence, associations with cardiovascular risk factors and contribution to survival in the Russian population
by: Yu. A. Balanova, et al.
Published: (2024-06-01)

Relationship of prognostic nutritional index with anemia and all-cause mortality: a NHANES study
by: Yongjin Zhi, et al.
Published: (2025-12-01)

Association of Diuretic Dosage With Outcomes in Patients With Hemodynamically Significant Isolated Tricuspid Valve Regurgitation
by: Vidhu Anand, et al.
Published: (2025-07-01)

The Associations Between Gallstone Disease and Pan‐Cancer Incidence Risk Based on Over 13 Million Participants
by: Wenqian Yu, et al.
Published: (2025-05-01)

Design and Implementation of PID Adaptation Mechanism for MRAS-Based Speed Estimation of Induction Machine
by: Mohamed Amine Fnaiech, et al.
Published: (2025-01-01)

Association of oxidative balance score with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease
by: Yucui Lin, et al.
Published: (2025-06-01)

IMPACT OF THE INFLAMMATORY AND ISCHEMIC HEART DISEASE MARKERS INTO THE OVERALL CARDIOVASCULAR MORTALITY IN SENILE CITIZENS OF A LARGE CITY (THE DATA FROM SAHR TRIAL)
by: S. A. Shalnova, et al.
Published: (2015-06-01)